Philip Rosen
Colon & Rectal Surgery · Tucson, AZNPI 1437595642
Payments from drug & device makers
What this record shows
This record is dominated by education: $11,082 of the $16,791 with a category attached, or 66.0%. Intuitive Surgical accounts for 90.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $10,237 and has fallen 76.9% since, to $2,362 in 2025.
Across 54 payments — averaging $310.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$15K
- Medtronic$975
- Avita Medical Americas, LLC$148
- Davol Inc.$134
- Boehringer Ingelheim$112
- Atricure, Inc.$109
- plus $62 from 1 others
What the payments were for
- Travel & lodging$4,20825%
- Food & beverage$1,4849%
- Education$11,08266%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 33 | $15,251 |
| Medtronic | 15 | $975 |
| Avita Medical Americas, LLC | 1 | $148 |
| Davol Inc. | 1 | $134 |
| Boehringer Ingelheim | 1 | $112 |
| Atricure, Inc. | 1 | $109 |
| Johnson & Johnson | 2 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$11,000
- Da Vinci Surgical System$3,764
- INTERSTIM$409
- RECELL$148
- Phasix Mesh$134
- JARDIANCE$112
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$109
How this compares
$16,791 in reported general payments places this provider in the 75th percentile of 50 colon & rectal surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LoperamideLoperamide Hcl | 20 | $814 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $315 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 16 | $251 |
| Omeprazole | 13 | $238 |
| Cyclobenzaprine Hcl | 13 | $144 |
| Neomycin Sulfate | 18 | $87 |
| Metronidazole | 17 | $30 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Tucson
- Stefanie SchluenderTucson$6K
- Jessica StephensTucson$5K
- Cybil CorningTucson$3K
- Susan ParkerTucson$20
- James KleinTucson$18
- Deborah KellerScottsdale$195K
- Eugene KimPhoenix$189K
- Sushil PandeySurprise$125K
- Hekmat HakimanChandler$57K
- Ashley CasanoPhoenix$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.